Freshwater: A prospective, multicentre, single-arm feasibility study examining novel treatment delivery of the Evoke Spinal Cord Stimulator (SCS) System to treat patients with chronic pain of the trunk and/or limbs.
Year: 2021
Type: Device
Phase: Post-Market
Indication: Back and/or Leg Pain, Chronic Trunk and/or Limb Pain, Neck / Upper Limb Pain
Upadacitinib treatment patterns, achievement of treatment targets and maintenance of response in moderate to severe Rheumatoid Arthritis patients in real-world practice (UPHOLD).
Year: 2020
Type: Musculoskeletal
Phase: Post-Market
Indication: Rheumatoid Arthritis
Real World Effectiveness of Upadacitinib on Early and Sustained Pain Control in Radiographic Axial Spondyloarthritis (UPSTAND).
Year: 2021
Type: Musculoskeletal
Phase: Post-Market
Indication: Spondyloarthritis
A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain (RELIEF-2).
Year: 2019
Type: Device
Phase: Post-Market
Indication: Back and/or Leg Pain, Chronic Trunk and/or Limb Pain, Neck / Upper Limb Pain
Partnership for Advancement in Neuromodulation (PAIN): A Prospective Clinical Outcomes Registry.
Year: 2012
Type: Device
Phase: Post-Market
Indication: Chronic Trunk and/or Limb Pain
A Multicenter Prospective Observational Study on the Safety and Efficacy of High Frequency Spinal Cord Stimulation in Complex Regional Pain Syndrome Patients.
Year: 2013
Type: Device
Phase: Post-Market
Indication: CRPS
A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain (RELIEF).
